发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| Australia | 1151 |
| CHINA MAINLAND | 147 |
| USA | 106 |
| Japan | 61 |
| England | 54 |
| South Korea | 38 |
| Canada | 36 |
| Singapore | 32 |
| France | 28 |
| Taiwan | 28 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| UNIVERSITY OF SYDNEY | 234 |
| UNIVERSITY OF NEWCASTLE | 175 |
| PETER MACCALLUM CANCER CENTER | 144 |
| UNIVERSITY OF MELBOURNE | 109 |
| UNIVERSITY OF NEW SOUTH WALES SYDNEY | 103 |
| HUNTER MEDICAL RESEARCH INSTITUTE | 102 |
| MONASH UNIVERSITY | 91 |
| UNIVERSITY OF QUEENSLAND | 88 |
| UNIVERSITY OF WESTERN AUSTRALIA | 77 |
| CALVARY MATER NEWCASTLE HOSPITAL | 76 |
文章引用情况
1
Phase II study of celecoxib with docetaxel chemoradiotherapy followed by consolidation chemotherapy docetaxel plus cisplatin with maintenance celecoxib in inoperable stage III nonsmall cell lung cancer2
Implementation of the Australasian Teletrial Model: Lessons from practice3
Morbidity and mortality of elderly patients following cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)4
The c-Myc-regulated miR-17-92 cluster mediates ATRA-induced APL cell differentiation5
The challenge of putting principles into practice: Resource tensions and real-world constraints in multidisciplinary oncology team meetings6
Cut-point for Ki-67 proliferation index as a prognostic marker for glioblastoma7
Real-world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma8
Risk, pattern and survival impact of second primary tumors in patients with nasopharyngeal carcinoma following definitive intensity-modulated radiotherapy9
Utilization of stereotactic ablative radiotherapy in oligometastatic & oligoprogressive skeletal metastases: Results and pattern of failure10
Re-inventing the randomized controlled trial in medical oncology: The registry-based trial